Interaction between redox regulation, immune activation, and response to treatment in HER2+ breast cancer

In HER2+ breast cancer (BC), neoadjuvant therapy represents an ideal scenario for translational research, considering pathological complete response (pCR) as an endpoint. In these patients, achieving pCR after neoadjuvant therapy is associated with a better prognosis. However, biomarkers are needed...

Full description

Saved in:
Bibliographic Details
Main Authors: Paulo Luz, Sofia Ramos, Maria José Oliveira, João G. Costa, Nuno Saraiva, Ana S. Fernandes
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Redox Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231725001223
Tags: Add Tag
No Tags, Be the first to tag this record!